Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3

Autor: Ying-Ming Pan, Jing Xiaoteng, Zhen-Feng Chen, Ri-Zhen Huang, Ye Zhang, Gui-Bin Liang, Yi-Lin Fang, Heng-Shan Wang, Xiaochao Huang, Zhi-Xin Liao
Rok vydání: 2020
Předmět:
STAT3 Transcription Factor
Mice
Nude

Antineoplastic Agents
01 natural sciences
03 medical and health sciences
chemistry.chemical_compound
Structure-Activity Relationship
In vivo
Cell Line
Tumor

Drug Discovery
Oximes
medicine
Structure–activity relationship
Animals
Humans
Immunologic Factors
Indoleamine-Pyrrole 2
3
-Dioxygenase

Doxorubicin
Enzyme Inhibitors
STAT3
Indoleamine 2
3-dioxygenase

030304 developmental biology
0303 health sciences
Tumor microenvironment
biology
Molecular Structure
Chemistry
Xenograft Model Antitumor Assays
Naphthoquinone
0104 chemical sciences
Mice
Inbred C57BL

Molecular Docking Simulation
010404 medicinal & biomolecular chemistry
STAT protein
biology.protein
Cancer research
Molecular Medicine
Tumor Escape
Drug Screening Assays
Antitumor

medicine.drug
Naphthoquinones
Zdroj: Journal of medicinal chemistry. 63(4)
ISSN: 1520-4804
Popis: Indoleamine-2,3-dioxygenase 1 (IDO1) and signal transducer and activator of transcription 3 (STAT3) are important targets in the tumor microenvironment for cancer therapy. In the present study, a set of naphthoquinone aromatic amide-oxime derivatives were designed, which stimulated the immune response via IDO1 inhibition and simultaneously displayed powerful antitumor activity against three selected cancer cell lines through suppressing STAT3 signaling. The representative compound 8u bound effectively to IDO1, with greater inhibitory activity relative to the commercial IDO1 inhibitor 4-amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide (IDO5L) in addition to the efficient suppression of nuclear translocation of STAT3. Consistently, in vivo assays demonstrated a higher antiproliferative activity of compound 8u in both wild-type B16-F10 isograft tumors and an athymic HepG2 xenograft model relative to 1-methyl-l-tryptophan (1-MT) and doxorubicin (DOX). This bifunctional compound with dual immunotherapeutic and anticancer efficacy may represent a new generation of highly efficacious drug candidates for cancer therapy.
Databáze: OpenAIRE